Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy Deposition Author(s): King, N.M. , Nalivaika, E.A. , Prabu-Jeyabalan, M. , Schiffer, C.A.
Date: 2002-09-20 Method: X-RAY DIFFRACTION Resolution: 1.9 Å Organism(s): Human Immunodeficiency Virus 1 , Synthetic Construct Sequences Data: 1MT7_A , 1MT7_B , 1MT7_P
Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy Deposition Author(s): King, N.M. , Nalivaika, E.A. , Prabu-Jeyabalan, M. , Schiffer, C.A.
Date: 2002-09-20 Method: X-RAY DIFFRACTION Resolution: 2.15 Å Organism(s): Human Immunodeficiency Virus 1 , Synthetic Construct Sequences Data: 1MT8_A , 1MT8_B , 1MT8_P
Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy Deposition Author(s): King, N.M. , Nalivaika, E.A. , Prabu-Jeyabalan, M. , Schiffer, C.A.
Date: 2002-09-20 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Human Immunodeficiency Virus 1 , Synthetic Construct Sequences Data: 1MT9_A , 1MT9_B , 1MT9_P
Viability of a drug-resistant hiv-1 protease mutant: structural insights for better antiviral therapy Deposition Author(s): King, N.M. , Nalivaika, E.A. , Prabu-Jeyabalan, M. , Schiffer, C.A.
Date: 2002-09-20 Method: X-RAY DIFFRACTION Resolution: 2.5 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 1MTB_A , 1MTB_B
Viability of a drug-resistant hiv-1 protease variant: structural insights for better anti-viral therapy Deposition Author(s): King, N.M. , Nalivaika, E.A. , Prabu-Jeyabalan, M. , Schiffer, C.A.
Date: 2002-10-30 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 1N49_A , 1N49_B , 1N49_C , 1N49_D
Hiv protease wild-type in complex with tmc114 inhibitor Deposition Author(s): De Bethune, M.P. , King, N.M. , Nalivaika, E.A. , Prabu-Jeyabalan, M. , Schiffer, C.A. , Wigernick, P.B.
Date: 2004-04-27 Method: X-RAY DIFFRACTION Resolution: 1.2 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 1T3R_A , 1T3R_B
The structural and thermodynamic basis for the binding of tmc114, a next-generation hiv-1 protease inhibitor. Deposition Author(s): De Bethune, M.-P. , King, N.M. , Nalivaika, E.A. , Prabu-Jeyabalan, M. , Schiffer, C.A. , Wigerinck, P.B.T.P.
Date: 2004-05-10 Method: X-RAY DIFFRACTION Resolution: 1.35 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 1T7I_A , 1T7I_B
Crystal structure of inhibitor amprenavir in complex with a multi-drug resistant variant of hiv-1 protease (l63p/v82t/i84v) Deposition Author(s): De Bethune, M.-P. , King, N.M. , Nalivaika, E.A. , Prabu-Jeyabalan, M. , Schiffer, C.A. , Wigerinck, P.B.T.P.
Date: 2004-05-10 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Human Immunodeficiency Virus 1 Sequences Data: 1T7J_A , 1T7J_B
Crystal structure of ap2v substrate variant of nc-p1 decamer peptide in complex with v82a/d25n hiv-1 protease mutant Deposition Author(s): King, N.M. , Nalivaika, E.A. , Prabu-Jeyabalan, M. , Schiffer, C.A.
Date: 2004-06-21 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): N.A. Sequences Data: 1TSQ_A , 1TSQ_B , 1TSQ_P
Crystal structure of decamer ncp1 substrate peptide in complex with wild-type d25n hiv-1 protease variant Deposition Author(s): King, N.M. , Nalivaika, E.A. , Prabu-Jeyabalan, M. , Schiffer, C.A.
Date: 2004-06-21 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): N.A. Sequences Data: 1TSU_A , 1TSU_B , 1TSU_P